Share This Page
Drug Price Trends for FT STOOL SOFTENER
✉ Email this page to a colleague
Average Pharmacy Cost for FT STOOL SOFTENER
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FT STOOL SOFTENER 100 MG TAB | 70677-1071-01 | 0.03882 | EACH | 2024-12-18 |
| FT STOOL SOFTENER 100 MG SFTGL | 70677-1095-02 | 0.02473 | EACH | 2024-12-18 |
| FT STOOL SOFTENER-STIM LAX TAB | 70677-1094-01 | 0.02824 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
FT STOOL SOFTENER Market Analysis and Financial Projection
Market Analysis and Price Projections for Stool Softeners
Market Overview
The stool softener market is experiencing significant growth, driven by several key factors. As of 2021, the global stool softener market size was valued at USD 1.53 billion and is projected to grow at a compound annual growth rate (CAGR) of 7.15% from 2022 to 2030, reaching USD 2.84 billion by 2030[5].
Key Drivers of Market Growth
- Aging Population: The increasing geriatric population suffering from constipation is a major driver. Older adults are more prone to constipation due to reduced physical activity, dietary changes, and the presence of chronic diseases[5].
- Sedentary Lifestyle: The rising adoption of sedentary lifestyles contributes to the growth, as lack of physical activity is a significant risk factor for constipation[5].
- Increased Healthcare Spending: Higher healthcare spending and increased public awareness about digestive health are also driving the market forward[1].
- Shift to Over-the-Counter Status: Many stool softeners are transitioning from prescription-only to over-the-counter status, making them more accessible and contributing to market growth[1].
Market Segmentation
The stool softener market is segmented in several ways:
By Type
- Liquid
- Softgel Capsule These forms cater to different patient preferences and needs[1].
By Form
- Medicines
- Procedures The market includes both medicinal products and procedural treatments for constipation[1].
By Mode of Administration
- Oral
- Rectal Oral administration is the most common, but rectal administration is also used in specific cases[1].
By Availability
- Over-The-Counter
- Prescription The shift towards over-the-counter availability is a significant trend[1].
By End Use
- Hospitals
- Clinics
- Home Care Home care was the leading segment in 2021, reflecting the preference for self-management of constipation[5].
Regional Analysis
- North America: This region is expected to register a rapid revenue growth rate due to the increasing prevalence of constipation in the pediatric population and the use of opioids, which can cause constipation[5].
- Europe: The market in Europe is driven by the rising incidence of Chronic Idiopathic Constipation (CIC) and other bowel disorders. Osmotic laxatives are often the first-line therapeutic approach in this region[5].
- Asia Pacific: This region is predicted to witness rapid growth due to the increasing prevalence of constipation and growing awareness of digestive health[3].
Competitive Landscape
The global stool softener market is fairly fragmented, with several large and medium-sized companies. Key players include:
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- AstraZeneca Plc.
- Abbott Laboratories Inc.
- Takeda Pharmaceutical Company Ltd.
- GlaxoSmithKline Plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Purdue Pharma L.P.
- Other notable companies[1][3][5].
Price Projections and Retail Prices
The prices of stool softeners can vary significantly depending on the pharmacy and the specific product.
| Pharmacy | Stool Softener Retail Price | SingleCare Price |
|---|---|---|
| Walgreens | $37.72 | $2.82 |
| Kroger Pharmacy | $19.09 | $6.84 |
| Albertsons Pharmacy | - | $6.97 |
| Rite Aid Pharmacy | $36.96 | $6.08 |
[2]
Challenges and Restraints
- Natural Alternatives: The availability of natural stool softening alternatives, such as high-fiber foods, can reduce consumer preference for pharmaceutical stool softening formulations[5].
- Product Recalls: Recalls due to microbial contamination, such as the detection of Burkholderia cepacia and B. pseudomallei, can significantly restrain market revenue growth[5].
Innovations and Trends
- Improvements in Medical Diagnostics and Treatments: Advances in medical diagnostics and the development of more effective stool softener formulations are expected to drive market growth[1].
- Personalized Stool Softener Products: The development of personalized stool softener products is a growing trend, catering to individual patient needs[1].
- Effervescent Stool Softener Tablets: Innovations in formulation technology, including the development of effervescent stool softener tablets, are also on the rise[1].
Macro Economic Scenario
The market is influenced by various macroeconomic factors:
- High Inflation: High inflation can impact the purchasing power of consumers, potentially affecting market growth[1].
- Ukraine-Russia War: Global conflicts can disrupt supply chains and affect the availability of raw materials, impacting the market[1].
- COVID-19 Impact: The pandemic has accelerated the focus on healthcare and digestive health, contributing to the growth of the stool softener market[1].
Key Takeaways
- The stool softener market is growing rapidly due to an aging population, sedentary lifestyles, and increased healthcare spending.
- The market is segmented by type, form, mode of administration, availability, and end use.
- North America and Europe are key regions driving market growth.
- Natural alternatives and product recalls are significant restraints.
- Innovations in medical diagnostics and personalized products are key trends.
FAQs
1. What is the projected CAGR for the stool softener market from 2022 to 2030? The stool softener market is expected to grow at a CAGR of 7.15% from 2022 to 2030[5].
2. Which region is expected to register rapid revenue growth in the stool softener market? North America is expected to register rapid revenue growth due to the increasing prevalence of constipation in the pediatric population and the use of opioids[5].
3. What are the main drivers of the stool softener market? The main drivers include an aging population, sedentary lifestyles, increased healthcare spending, and the shift of many stool softeners from prescription-only to over-the-counter status[1][5].
4. Which companies are major players in the stool softener market? Key players include F. Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca Plc., Abbott Laboratories Inc., and Takeda Pharmaceutical Company Ltd., among others[1][3][5].
5. What are some of the restraints affecting the stool softener market? Natural alternatives and product recalls due to microbial contamination are significant restraints affecting the market[5].
Cited Sources
- The Business Research Company - Stool Softener Global Market Report 2024
- SingleCare - Stool Softener Coupons & Prices
- Global Market Estimates - Constipation Laxative Market Analysis | Size & Forecasts
- Allied Market Research - Constipation Treatment Market Size, and Forecast- 2032
- Emergen Research - Stool Softener Industry Trend, Forecast [2021-2030] | Market ...
More… ↓
